119 related articles for article (PubMed ID: 11835193)
21. Pharmacokinetic disposition of a long-acting oxytetracycline formulation after single-dose intravenous and intramuscular administrations in the American alligator (Alligator mississippiensis).
Helmick KE; Papich MG; Vliet KA; Bennett RA; Jacobson ER
J Zoo Wildl Med; 2004 Sep; 35(3):341-6. PubMed ID: 15526889
[TBL] [Abstract][Full Text] [Related]
22. Interspecies scaling and comparisons in drug development and toxicokinetics.
Ings RM
Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
[TBL] [Abstract][Full Text] [Related]
23. Allometric analysis of thiamphenicol disposition among seven mammalian species.
Castells G; Capece BP; Pérez F; Martí G; Arboix M; Cristòfol C
J Vet Pharmacol Ther; 2001 Jun; 24(3):193-7. PubMed ID: 11442797
[TBL] [Abstract][Full Text] [Related]
24. Determination of oxytetracycline in biological matrix.
Kowalski C; Pomorska M; Lebkowska B; Sławik T
Acta Pol Pharm; 2006; 63(5):409-11. PubMed ID: 17357597
[No Abstract] [Full Text] [Related]
25. Pharmacokinetics of a long-acting oxytetracycline-polyethylene glycol formulation in horses.
Dowling PM; Russell AM
J Vet Pharmacol Ther; 2000 Apr; 23(2):107-10. PubMed ID: 10849256
[No Abstract] [Full Text] [Related]
26. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Potter T; Pelligand L; Toutain PL
J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
[TBL] [Abstract][Full Text] [Related]
27. Is the current dose of a conventional oxytetracycline formulation adequate for the management of infections in sheep?
Snyman MG; Naidoo V; de Bruin C; Swan GE
J S Afr Vet Assoc; 2008 Dec; 79(4):171-4. PubMed ID: 19496316
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline administered alone and in combination with carprofen in calves.
Brentnall C; Cheng Z; McKellar QA; Lees P
Res Vet Sci; 2013 Jun; 94(3):687-94. PubMed ID: 23415880
[TBL] [Abstract][Full Text] [Related]
29. Disposition of a long-acting oxytetracycline formulation in Thai swamp buffaloes (Bubalus bubalis).
Poapolathep S; Wongpanit K; Imsilp K; Tanhan P; Klangkaew N; Giorgi M; Poapolathep A
J Vet Pharmacol Ther; 2017 Apr; 40(2):206-209. PubMed ID: 27597645
[TBL] [Abstract][Full Text] [Related]
30. Interspecies variation in the plasma halflife of oxytetracycline in relation to bodyweight.
Kirkwood JK; Widdowson MA
Res Vet Sci; 1990 Mar; 48(2):180-3. PubMed ID: 2333426
[TBL] [Abstract][Full Text] [Related]
31. Allometric scaling of orbifloxacin disposition in nine mammal species: a retrospective analysis.
Gebru E; Lee SJ; Kim JC; Park SC
J Vet Med Sci; 2011 Jun; 73(6):817-20. PubMed ID: 21233597
[TBL] [Abstract][Full Text] [Related]
32. Physiological parameter values for physiologically based pharmacokinetic models in food-producing animals. Part III: Sheep and goat.
Li M; Wang YS; Elwell-Cuddy T; Baynes RE; Tell LA; Davis JL; Maunsell FP; Riviere JE; Lin Z
J Vet Pharmacol Ther; 2021 Jul; 44(4):456-477. PubMed ID: 33350478
[TBL] [Abstract][Full Text] [Related]
33. Species scaling of propafenone disposition and concentration--time relationships among eight mammalian species.
Puigdemont A; Ramis J; Guitart R; Arboix M
J Pharm Sci; 1993 Nov; 82(11):1126-9. PubMed ID: 8289126
[TBL] [Abstract][Full Text] [Related]
34. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.
Lave T; Levet-Trafit B; Schmitt-Hoffmann AH; Morgenroth B; Richter W; Chou RC
J Pharm Sci; 1995 Nov; 84(11):1285-90. PubMed ID: 8587044
[TBL] [Abstract][Full Text] [Related]
35. The effects of the method of calculation on the evaluation of the pharmacokinetic parameters of oxytetracycline after intravenous administration to calves.
Errecalde JO; Mestorino N; Mariño EL
Vet Res Commun; 1997 May; 21(4):273-81. PubMed ID: 9151411
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and tissue residues of an oxytetracycline/diclofenac combination in cattle.
Mestorino N; Mariño Hernández E; Marchetti L; Errecalde JO
Rev Sci Tech; 2007 Dec; 26(3):679-90. PubMed ID: 18293616
[TBL] [Abstract][Full Text] [Related]
37. Mixed effect modeling of sumatriptan pharmacokinetics during drug development. I: Interspecies allometric scaling.
Cosson VF; Fuseau E; Efthymiopoulos C; Bye A
J Pharmacokinet Biopharm; 1997 Apr; 25(2):149-67. PubMed ID: 9408857
[TBL] [Abstract][Full Text] [Related]
38. Performance Assessment and Translation of Physiologically Based Pharmacokinetic Models From acslX to Berkeley Madonna, MATLAB, and R Language: Oxytetracycline and Gold Nanoparticles As Case Examples.
Lin Z; Jaberi-Douraki M; He C; Jin S; Yang RSH; Fisher JW; Riviere JE
Toxicol Sci; 2017 Jul; 158(1):23-35. PubMed ID: 28402537
[TBL] [Abstract][Full Text] [Related]
39. Effects of experimentally induced Theileria annulata infection on the pharmacokinetics of oxytetracycline in cross-bred calves.
Kumar R; Malik JK
Vet Res; 1999; 30(1):75-86. PubMed ID: 10081114
[TBL] [Abstract][Full Text] [Related]
40. Risk-based approach to developing a national residue sampling plan for testing under European Union regulation for veterinary medicinal products and coccidiostat feed additives in domestic animal production.
Danaher M; Shanahan C; Butler F; Evans R; O'Sullivan D; Glynn D; Camon T; Lawlor P; O'Keeffe M
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2016 Jul; 33(7):1155-65. PubMed ID: 27189753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
